Man Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64M Buy
69,600
+3,300
+5% +$3.35M 0.12% 187
2025
Q4
$71.3M Buy
66,300
+17,000
+34% +$16.3M 0.12% 179
2025
Q3
$37.6M Sell
49,300
-13,700
-22% -$10.2M 0.07% 324
2025
Q2
$49.1M Sell
63,000
-12,100
-16% -$9.4M 0.09% 241
2025
Q1
$62M Sell
75,100
-4,900
-6% -$4.08M 0.16% 142
2024
Q4
$61.8M Buy
80,000
+31,200
+64% +$25.8M 0.16% 141
2024
Q3
$43.2M Buy
48,800
+20,300
+71% +$18.3M 0.11% 230
2024
Q2
$25.8M Buy
28,500
+11,400
+67% +$9.12M 0.07% 360
2024
Q1
$13.3M Sell
17,100
-2,100
-11% -$1.49M 0.03% 583
2023
Q4
$11.2M Buy
+19,200
New +$11.2M 0.03% 594
2021
Q4
Sell
-1,600
Closed -$370K 2035
2021
Q3
$370K Buy
1,600
+1,500
+1,500% +$370K ﹤0.01% 1608
2021
Q2
$23K Buy
+100
New +$20.1K ﹤0.01% 1915

Other funds holding LLY

Man Group's LLY Position: Q1 2026 in Review

Man Group increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $61.8M and bringing the position to 422,016 shares worth $388M. The position accounts for 0.7% of the portfolio, ranked #11.

Man Group first reported a position in LLY in Q1 2018 and has held it in 30 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Man Group held 422,016 shares of Eli Lilly worth $388M as of Q1 2026.
  • Man Group bought 60,956 Eli Lilly shares in Q1 2026, an estimated $61.8M.
  • Eli Lilly made up 0.7% of Man Group's portfolio in Q1 2026, its #11 holding.
  • Man Group first reported a position in Eli Lilly in Q1 2018 and has held it in 30 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.